Review

Added sugars and risk factors for obesity, diabetes and heart disease

  • International Journal of Obesity 40, S22S27 (2016)
  • doi:10.1038/ijo.2016.10
  • Download Citation
Published online:

This article is based on a presentation at a symposium entitled ‘Sweeteners and Health: Findings from Recent Research and their Impact on Obesity and Related Metabolic Conditions’ held at the European Congress on Obesity (ECO) on 7 May 2015. This symposium was supported, in part, by an educational grant from Rippe Lifestyle Institute.

Abstract

The effects of added sugars on various chronic conditions are highly controversial. Some investigators have argued that added sugars increase the risk of obesity, diabetes and cardiovascular disease. However, few randomized controlled trials are available to support these assertions. The literature is further complicated by animal studies, as well as studies which compare pure fructose to pure glucose (neither of which is consumed to any appreciable degree in the human diet) and studies where large doses of added sugars beyond normal levels of human consumption have been administered. Various scientific and public health organizations have offered disparate recommendations for upper limits of added sugar. In this article, we will review recent randomized controlled trials and prospective cohort studies. We conclude that the normal added sugars in the human diet (for example, sucrose, high-fructose corn syrup and isoglucose) when consumed within the normal range of normal human consumption or substituted isoenergetically for other carbohydrates, do not appear to cause a unique risk of obesity, diabetes or cardiovascular disease.

  • Subscribe to International Journal of Obesity for full access:

    $652

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , . Sucrose, high-fructose corn syrup, and fructose, their metabolism and potential health effects: what do we really know? Adv Nutr 2013; 4: 236–245.

  2. 2.

    . The metabolic and endocrine response and health implications of consuming sweetened beverages: findings from recent, randomized, controlled trials. Adv Nutr 2013; 4: 677–686.

  3. 3.

    , . Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? We have, but the pox on sugar is overwrought and overworked. Diabetes Care 2014; 37: 957–962.

  4. 4.

    , . Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? Health Be Damned! Pour on the Sugar. Diabetes Care 2014; 37: 950–956.

  5. 5.

    , , , . Lack of evidence for high fructose corn syrup as the cause of the obesity epidemic. Int J Obes (Lond) 2012; 27: 771–773.

  6. 6.

    , , . Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537–543.

  7. 7.

    . Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 2010; 110: 1307–1321.

  8. 8.

    , , . Public health: the toxic truth about sugar. Nature 2012; 482: 27–29.

  9. 9.

    . Fructose: pure, white, and deadly? Fructose, by any other name, is a health hazard. J Diabetes Sci Technol 2010; 4: 1003–1007.

  10. 10.

    . The health implications of sucrose, high-fructose corn syrup, and fructose: what do we really know? J Diabetes Sci Technol 4: 1008–10112010.

  11. 11.

    , , , . Is fructose a story of mice but not men? J Am Diet Assoc 2011; 111: 219–220, author reply 220–212.

  12. 12.

    , , . Misconceptions about fructose-containing sugars and their role in the obesity epidemic. Nutr Res Rev 2014; 27: 199–130.

  13. 13.

    . Straight talk about high-fructose corn syrup. What it is and what it ain't. Am J Clin Nutr 2008; 88: 1716S–1721S.

  14. 14.

    . Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism. Adv Nutr 2013; 4: 246–256.

  15. 15.

    , . Sugars and Health Controversies. What does the Science Say? Adv Nutr 2015; 6 (Suppl): 493S–503S.

  16. 16.

    , , , , , . Do fructose-containing sugars lead to adverse health consequences? Results of recent systematic reviews and meta-analyses. Adv Nutri 2015; 6: 504S–511S.

  17. 17.

    , , , . Fructose containing sugars do not raise blood pressure or uric acid at normal levels of human consumption. J Clin Hypertens 2014; 17: 87–94.

  18. 18.

    , , , . The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One 2013; 8: e57873.

  19. 19.

    , , . High fructose corn syrup and diabetes prevalence: a global perspective. Glob Public Health 2013; 8: 55–64.

  20. 20.

    , , , . Dietary sugars and cardiometabolic risk: Systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clinic Nutr 2014; 100: 65–79.

  21. 21.

    Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2015. US Department of Agriculture, Center for Nutrition Policy and Promotion, Washington, DC, USA.

  22. 22.

    , . Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose or high-fructose corn syrup. Am J Clin Nutr 2008; 88: 1733S–1737S.

  23. 23.

    , , , , , . Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009; 94: 1562–1559.

  24. 24.

    , , , , , et al. Consumption of fructose-, but not glucose sweetened beverages produces an atherogenic lipid profile in overweight/obese men and women. Diabetes 2007; 56 (Suppl 1): A16.

  25. 25.

    . Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005; 63: 133–157.

  26. 26.

    , , , , , et al. Dietary sugars intake and cardiovascular health, a scientific statement from the American Heart Association. Circulation 2009; 120: 1011–1020.

  27. 27.

    Scientific Advisory Committee on Nutrition. Draft Carbohydrates and Health Report, 2014. Available from .

  28. 28.

    World Health OrganizationThe Global Burden of Disease: 2004 Update. World Health Organization: Geneva, Switzerland, 2008.

  29. 29.

    Institute of MedicineDietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Institute of Medicine of the National Academies. National Academies Press: Washington, DC, USA, 2005.

  30. 30.

    Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. US Department of Agriculture, Center for Nutrition Policy and Promotion, Washington, DC, USA.

  31. 31.

    . Sucrose, HFCS, and fructose: history, manufacture, composition, applications, and production. In: Rippe JM (ed). Fructose, High Fructose Corn Syrup, Sucrose and Health. Springer Publishing: New York, NY, USA, 2014.

  32. 32.

    , . Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010; 90: 23–46.

  33. 33.

    , . Fructose metabolism in humans: what isotopic tracer studies tell us. Nutr Metab 2012; 9: 89.

  34. 34.

    , , . Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996; 16: 523–557.

  35. 35.

    USDA-ERS. Food Availability (Per capita) Data System: Loss-adjusted food availability [Internet]. Sugar and sweeteners (added), sugar.xls, updated 4 December 2014 [cited 10 March 2015]. Available from .

  36. 36.

    , , , . Consumption of added sugars is decreasing in the United States. Am J Clin Nutr 2011; 94: 726–734.

  37. 37.

    . Pure, White and Deadly. Penguin Books: New York, NY, USA, 1972.

  38. 38.

    . Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease. Harvard University Press: Cambridge, MA, USA, 1980; 1–381.

  39. 39.

    , , , , , et al. Body composition, dietary composition, and components of metabolic syndrome in overweight and obese adults after a 12-week trial on dietary treatments focused on portion control, energy density, or glycemic index. Nutr J 2012; 11: 57.

  40. 40.

    , , , , , . Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition 2007; 23: 103–112.

  41. 41.

    , , . High-fructose corn syrup and sucrose have equivalent effects on energy-regulating hormones at normal human consumption levels. Nutr Res 2013; 33: 1043–1052.

  42. 42.

    , . No differences in satiety or energy intake after high fructose corn syrup, sucrose, or milk preloads. Am J Clin Nutr 2007; 86: 1586–1594.

  43. 43.

    , , , , , et al. The effect of normally consumed amounts of sucrose or high fructose corn syrup on body composition and related parameters in overweight/obese subjects. Nutrients 2014; 6: 1128–114.

  44. 44.

    , , , . Will reducing sugar-sweetened beverage consumption reduce obesity? Evidence supporting conjecture is strong, but evidence when testing effect is weak. Obes Rev 2013; 14: 620–633.

  45. 45.

    , , . Dietary sugars and body weight: systematic review and meta-analysis of randomized controlled trials and cohort studies. BMJ 2013; 346: e7492.

  46. 46.

    , , , . Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutri 2013; 98: 1084–1102.

  47. 47.

    , . Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings? Curr Diab Rep 2015; 15: 1–12.

  48. 48.

    , , , . Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235–241.

  49. 49.

    , , , . Sweeteners and diabetes. In: Rippe J (ed). Fructose, High Fructose Corn Syrup, Sucrose and Health. Springer Publishing: New York, NY, USA, 2014.

  50. 50.

    , . The Australian Paradox: a substantial decline in sugars intake over the same timeframe that overweight and obesity have increased [published erratum appears in Nutrients 2014; 6: 663–664]. Nutrients 2011; 3: 491–504.

  51. 51.

    , , , , , . Energy balance and its components: implications for body weight regulation. Am J Clin Nutri 2012; 95: 989–994.

  52. 52.

    International Diabetes Federation, IDF Diabetes Atlas. Epidemiology and Morbidity, 2015. International Diabetes Federation Available from .

  53. 53.

    , , , , , . Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33: 2477–2483.

  54. 54.

    , , , , . A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care 2003; 26: 1008–1015.

  55. 55.

    , , , . Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004; 27: 2701–2706.

  56. 56.

    , , , , , . Diet and risk of clinical diabetes in women. Am J Clin Nutri 1992; 55: 1018–1023.

  57. 57.

    , , , , . The effects of fructose containing sugars on weight, body composition and cardiometabolic risk factors when consumed at up to the 90th percentile population consumption level for fructose. Nutrients 2014; 6: 3153–3168.

  58. 58.

    , , . No change in oral glucose tolerance tests as a result of ten weeks of consumption of various fructose containing sugars or glucose. Diabetes: Clinical Physiology and Treatment SUN-1018-SUN-1018. The Endocrine Society 2014. Available from .

  59. 59.

    , , . No effect of added sugar consumed at median american intake level on glucose tolerance or insulin resistance. Nutrients 2015; 7: 8830–8845.

  60. 60.

    , , , , . Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab 2013; 38: 681–688.

  61. 61.

    , . Fructose containing sugars and cardiovascular disease. Adv Nutr 2015; 6: 430–439.

  62. 62.

    , , , , , et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011; 94: 479–485.

  63. 63.

    , , , , . Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 3. Synergistic effect of sucrose and animal fat on serum lipids. Atherosclerosis 1970; 11: 191–201.

  64. 64.

    , , , . Metabolic effects of dietary sucrose in type 2 diabetic subjects. Diabetes Care 1993; 16: 1301–1305.

  65. 65.

    , , , , , et al. Effect of eucaloric high- and low-sucrose diets with identical macronutrient profile on insulin resistance and vascular risk: a randomized controlled trial. Diabetes 2006; 55: 3566–3572.

  66. 66.

    , , . Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects. Diabet Med 1988; 5: 676–680.

  67. 67.

    , , , . Effect of interchanging bread and sucrose as main source of carbohydrate in a low fat diet on the serum cholesterol levels of healthy volunteer subjects. Am J Clin Nutr 1966; 19: 46–58.

  68. 68.

    , , , , , et al. The effects of four hypocaloric diets containing different levels of sucrose or high fructose corn syrup on weight loss and related parameters. Nutr J 2012; 11: 55.

  69. 69.

    , , , , , et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012; 95: 283–289.

  70. 70.

    , , . Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: effects on blood lipids, factor vii coagulant activity, and fibrinogen. Metabolism 2000; 49: 731–735.

  71. 71.

    , , , . Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002; 76: 721–729.

  72. 72.

    , , , . Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr 2005; 82: 421–427.

  73. 73.

    , , , , , . Twenty four hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 2008; 87: 1194–1203.

  74. 74.

    , , , , , et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-b in young men and women. J Clin Endocrinol Metab 2011; 96: E1596–E1605.

  75. 75.

    , , , , , et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 2292–2333.

  76. 76.

    , , , , , et al. The effect of normally consumed amounts of sucrose or high fructose corn syrup on body composition and related parameters in overweight/obese subjects. Nutrients 2014; 6: 1128–1144.

  77. 77.

    , , , , , et al. Does fructose consumption elicit a dose-response effect on fasting triglycerides? A systematic review and meta-regression of controlled feeding trials. Can J Diabetes 2012; 36: S37.

  78. 78.

    , , , , , et al. Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014; 232: 125–133.

  79. 79.

    , , , , , et alDASH Research Group. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001; 74: 80–89.

  80. 80.

    , , , , , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 655–666.

  81. 81.

    , . Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008; 19: 16–24.

  82. 82.

    . Dietary treatment of thrombogenic disorders related to the metabolic syndrome. Br J Nutr 2000; 83 (Suppl 1): S121–S126.

  83. 83.

    , , , , , et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899–906.

  84. 84.

    , , . Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300: 924–932.

  85. 85.

    , , , , , et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012; 59: 787–795.

  86. 86.

    , , , . Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009; 154: 807–813.

  87. 87.

    , , . Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999–2004 National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2009; 163: 328–335.

Download references

Acknowledgements

This article is based on a symposium entitled ‘Sweeteners and Health: Findings from Recent Research and their Impact on Obesity and Related Metabolic Conditions’ presented at the 22nd European Congress on Obesity, Prague, on 7 May 2015 with sponsorship from Rippe Lifestyle Institute.

Author information

Affiliations

  1. Rippe Lifestyle Institute, Shrewsbury, MA, USA

    • J M Rippe
  2. Rippe Lifestyle Research Institute of Florida, Celebration, FL, USA

    • J M Rippe
  3. University of Central Florida, Orlando, FL, USA

    • J M Rippe
  4. School of Health Sciences, Emory and Henry College, Emory, VA, USA

    • T J Angelopoulos

Authors

  1. Search for J M Rippe in:

  2. Search for T J Angelopoulos in:

Competing interests

JMR and Rippe's research laboratory have received unrestricted grants and JMR has received consulting fees from ConAgra Foods, Kraft Foods, Florida, Department of Citrus, PepsiCo International, The Coca Cola Company, Dr. Pepper/Snapple Group, Corn Refiners Association, Weight Watchers International as well as royalties and editorial office support from CRC Press, Sage Publishing and Springer Publishers. The remaining author (TJA) declares no conflict of interest.

Corresponding author

Correspondence to J M Rippe.